CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis. This evidence concerns the gene SPP1 and metabolic dysfunction-associated steatohepatitis.